Inactivation of the DNA-Repair Gene MGMT and the Clinical Response of Gliomas to Alkylating Agents
β Scribed by Esteller, Manel; Garcia-Foncillas, Jesus; Andion, Esther; Goodman, Steven N.; Hidalgo, Oscar F.; Vanaclocha, Vicente; Baylin, Stephen B.; Herman, James G.
- Book ID
- 121206093
- Publisher
- Massachusetts Medical Society
- Year
- 2000
- Tongue
- English
- Weight
- 487 KB
- Volume
- 343
- Category
- Article
- ISSN
- 0096-6762
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract DNA damage was evaluated by flow cytometric (FCM) analysis of cells treated with Lβphenylalanine mustard (LβPAM) and stained with antiβDNA monoclonal antibody (MAb) F7β26. DNA damage was rapidly repaired, as indicated by the loss of DNA immunoreactivity after removal of LβPAM. Two types
Acquired resistance to antineoplastic agents is a frequent obstacle in tumor therapy. Malignant melanoma cells are particularly well known for their unresponsiveness to chemotherapy; only about 30% of tumors exhibit a transient clinical response to treatment. In our study, we investigated the molecu
## Abstract Rates of adenocarcinoma of the esophagus (EAC) and esophagoβgastric junction (EGJAC) have increased rapidly in recent decades. The primary risk factors, gastroβesophageal acid reflux and smoking, are potentially genotoxic through the generation of __N__βnitroso compounds. The DNA repair